Skip to main content

Advertisement

SpringerLink
Log in

Early diagnosis of inherited metabolic disorders towards improving outcome: the controversial issue of galactosaemia

  • Article
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Galactosaemia due to galactose-1-phosphate uridyltransferase deficiency is a rare disease (1:40,000). Nationwide newborn screening for galactosaemia is performed in many countries; however, several countries do not screen for galactosaemia due to early manifestation of clinical symptoms and low incidence of the disease. In a German retrospective study, 148 galactosaemic patients born between 1955 and 1995, were evaluated. At least in Germany, newborn screening for galactosaemia, performed at day 5, was able to reduce or prevent the acute morbidity and mortality of the disease. The results should be even better if newborn screening takes place at day 3 using combined substrate screening and enzymatic testing for galactose-1-phosphate-uridyltransferase deficiency. Conclusion:newborn screening for classical galactosaemia does not change the long-term complications of the disease such as speech disorders, mental retardation, ataxia and in females hypergonadotropic hypogonadism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Anonymous (1982) Clouds over galactosemia. Lancet II: 1379–1380

    Google Scholar 

  2. Böhles H, Wenzel D, Shin YS (1986) Progressive cerebellar and extrapyramidal motor disturbances in galactosaemic twins. Eur J Pediatr 145: 413–417

    PubMed  Google Scholar 

  3. Beutler E, Baluda MC (1966) A simple spot screening test for galactosemia. J Lab Clin Med 68: 137–141

    PubMed  Google Scholar 

  4. Beutler E, Baluda M, Donnell GN (1964) A new method for the detection of galactosemia and its carrier state. J Lab Clin Med 64: 694–705

    PubMed  Google Scholar 

  5. Diepenbrock F, Heckler R, Schickling H, Engelhard T, Bock D, Sander J (1992) Colorimetric determination of galactose and galactose-1-phosphate from dried blood. Clin Biochem 25: 37–39

    PubMed  Google Scholar 

  6. Fishler K, Koch R, Donnell GN, Wenz E (1980) Developmental aspects of galactosemia from infancy to childhood. Clin Pediatr 19: 38–44

    CAS  Google Scholar 

  7. Gitzelmann R (2000) Disorders of galactose metabolism. In: Fernandes J, Saudubray J-M, van den Berghe G (eds) Inborn metabolic diseases, 3rd edn. Springer, Berlin Heidelberg New York, pp 103–109

  8. Gitzelmann R, Steinmann B (1984) Galactosemia: How does long-term treatment change the outcome? Enzyme 32: 37–46

    PubMed  Google Scholar 

  9. Hansen TWR, Lie SO (1988) Galactosemia—to screen or not to screen? Pediatrics 81: 327–328

    PubMed  Google Scholar 

  10. Holton JB (1990) Galactose disorders: an overview. J Inherit Metab Dis 13: 476–486

    PubMed  Google Scholar 

  11. Holton JB, Walter JH, Tyfield LA (2001) Galactosemia. In: Scriver CR, Beaudet aL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1553–1587

  12. Honeyman MM, Green A, Holton JB, Leonard JV (1993) Galactosemia: results of the British Paediatric Surveillance Unit study, 1988–1990. Arch Dis Child 69: 339–341

    PubMed  Google Scholar 

  13. Jan JE, Wilson RA (1973) Unusual late neurological sequelae in galactosaemia. Dev Med Child Neurol 15: 72–74

    PubMed  Google Scholar 

  14. Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R (1981) Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 304: 994–998

    Google Scholar 

  15. Komrower GM (1982) Galactosaemia—thirty years on. The experience of a generation. F.P. Hudson Memorial Lecture. J Inherit Metab Dis 5[Suppl 2]: 96–104

  16. Komrower GM, Lee DH (1970) Long-term follow-up of galactosemia. Arch Dis Child 45: 367–373

    PubMed  Google Scholar 

  17. Kurz G, Wallenfels K (1979) D-Galaktose: UV-Test mit Galaktose-Dehydrogenase. In: Bergmeyer H-U (ed) Methoden der enzymatischen Analyse. Chemie, Weinheim, pp 1241–1244

  18. Paigen K, Pacholec F, Levy HL (1982) A new method for screening for inherited disorders of galactose metabolism. J Lab Clin Med 99: 895–907

    PubMed  Google Scholar 

  19. Radomyska B (2001) Effectiveness of the screening programme for galactosemia. New strategy in Poland. Med Wieku Rozwoj 5: 51–58

    PubMed  Google Scholar 

  20. Scheibenreiter S, Knoll E, Widhalm K (1992) Langzeitergebnisse von Kindern mit klassischer Galaktosämie. Wien Klin Wochenschr 104: 514–517

    PubMed  Google Scholar 

  21. Schickling H, Schweitzer S, Shin Y, Diepenbrock F, Sander J (1994) Neonatal screening for galactose metabolic defects. In: Farriaux JP, Dhondt JL (eds) New horizons in neonatal screening. Elsevier Science BV, Amsterdam, pp 185–189

  22. Schweitzer S (1995) Newborn mass screening for galactosemia. Eur J Pediatr 154[Suppl 2]: S37–S39

  23. Schweitzer S, Shin J, Jakobs C, Brodehl J (1993) Long-term outcome in 134 patients with galactosaemia. Eur J Pediatr 152: 36–43

    CAS  PubMed  Google Scholar 

  24. Schweitzer-Krantz S (1997) Klinik, Verlauf und Langzeitprognose bei Galaktose-1-Phosphat-Uridyltransferase-Mangel (Galaktosämie). Habilitationsschrift, Medizinische Hochschule Hannover

  25. Waggoner DD, Buist NR, Donnell GN (1990) Long-term prognosis in galactosaemia: result of a survey of 350 cases. J Inherit Metab Dis 13: 802–818

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Evangelisches Krankenhaus Düsseldorf, Children’s Hospital, Kirchfeldstrasse. 40, 40217 , Düsseldorf, Germany

    Susanne Schweitzer-Krantz

Authors
  1. Susanne Schweitzer-Krantz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susanne Schweitzer-Krantz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schweitzer-Krantz, S. Early diagnosis of inherited metabolic disorders towards improving outcome: the controversial issue of galactosaemia. Eur J Pediatr 162 (Suppl 1), S50–S53 (2003). https://doi.org/10.1007/s00431-003-1352-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-003-1352-2

Keywords

Search

Navigation